HanauerSBFeaganBGLichtensteinGR; ACCENT I Study Group. Maintenance infliximab for Crohn’s disease. Lancet. 2002;359(9317):1541-1549.
2.
HanauerSBSandbornWJRutgeertsP. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease. Gastroenterology. 2006;130:323-333.
3.
SandbornWJFeaganBGStoinovS; PRECISE 1 Study Investigators. Certolizumab pegol for the treatment of Crohn’s disease. N Engl J Med. 2007;357:228-238.
4.
SandbornWJHanauerSBRutgeertsP. Adalimumab for maintenance treatment of Crohn’s disease. Gut. 2007;56(9):1232-1239.
5.
ColombelJFSandbornWJRutgeertsP. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease. Gastroenterology. 2007;132:52-65.
6.
ColombelJFSandbornWHReinischW. Infliximab, azathioprine, or combination therapy for Crohn’s disease. New Engl J Med. 2010;362:1383.
7.
ZatorZACantuSMKonijetiGG. Pretreatment 25-hydroxyvitamin D levels and durability of anti–tumor necrosis factor–α therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. 2014;38:385-391.
8.
FroicuMCantornaMT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007;8:5.
BlanckSAberraF. Vitamin D deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci. 2013;58(6):1698-1702.
11.
AnanthakrishnanANCaganAGainerVS. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm Bowel Dis. 2013;19(9):1921-1927.
12.
SamsonCMMorganPWilliamsE. Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2012;55(6):679-688.
BrehmJMSchuemannBFuhlbriggeAL. Childhood Asthma Management Program Research Group. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010;126(1):25-58e5.
15.
SearingDAZhangYMurphyJR. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol. 2010;125(5):996-1000.
16.
LitonjuaAA. Vitamin D and corticosteroids in asthma: synergy, interaction and potential therapeutic effects. Expert Rev Respir Med. 2013;7(2):101-104.
17.
BartelsLEJørgensenSPBendixM. 25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn’s disease. Inflammopharmacology. 2013;21(3):177-186.
18.
KarimYTurnerCDaltonN. The relationship between proinflammatory cytokines and the effect of high dose vitamin D supplementation on their circulating concentrations. Int Immunopharmacol. 2013;17(3):693-697.
19.
KuoYTKuoCHLamKP. Effects of vitamin D3 on expression of tumor necrosis factor-alpha and chemokines by monocytes. J Food Sci. 2010;75(6):H200-H204.
20.
KwonHJWonYSSuhHW. Vitamin D3 upregulated protein 1 suppresses TNF-a-induced NF-kB activation in hepatocarcinogenesis. J Immunol. 2010;185(7):3980-3989.
